Viramal

Viramal Overview

  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Series B
  • (Cancelled)
  • Investors
  • 1

Viramal General Information

Description

Developer of pharmaceutical drugs intended to improve the quality of women's health worldwide. The company's drugs provides treatments for fertility, menopausal hormone therapy, contraception, vaginal dryness and other sexual conditions with better safety, efficacy and patient acceptability with fewer side effects, enabling women to make their sexual health better safely and effectively.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 22 South Molton Street
  • London W1K 5RB
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Viramal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) Cancelled Clinical Trials - General
3. Early Stage VC (Series A) 03-Sep-2019 00.000 00.000 000.00 Completed Clinical Trials - General
2. Early Stage VC 01-Apr-2016 $4.81M $5.93M 000.00 Completed Clinical Trials - General
1. Angel (individual) 19-May-2014 $1.12M $1.12M 00.000 Completed Clinical Trials - General

Viramal Cap Table

To view Viramal‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.00
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 201,560 $0.012155 $1.52 $1.52 1x $1.52 7.04%
Ordinary 126,686 $0.012155 $1.06 $1.06 1x $1.06 4.43%

Viramal Executive Team (5)

Name Title Board Seat Contact Info
Oliver Bates Co-Founder, Chief Executive Officer & Board Member
Simon Holden Board Member & General Council and Company Secretary
Peter Fitzwilliam Chief Financial Officer
Finn Larsen MD Chief Medical and Development Officer & Co-founder

1 Former Executive

Viramal Board Members (6)

To view Viramal‘s full board member team, request access »
Name Representing Role Since
Jonathan Synett NCL Technology Ventures Board Member 000 0000
Marian Pardo Self Board Member 000 0000
Nick Thornilley Self Board Member 000 0000
Oliver Bates Viramal Co-Founder, Chief Executive Officer & Board Member 000 0000
Simon Holden Viramal Board Member & General Council and Company Secretary 000 0000

1 Former Board Member

Viramal Investors (1)

To view Viramal‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NCL Technology Ventures Venture Capital Minority 000 0000 000000 0

Viramal Investments (1)

To view Viramal‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 01-Mar-2015 000000000 00000 00 Other Commercial Services 000000 00000

Ready to get started?

Request a free trial